Sept7 coordinates cytoskeletal dynamics and MAPK/ERK1/2 signaling to orchestrate OPC differentiation and myelination
This study demonstrates that Sept7 orchestrates oligodendrocyte differentiation and myelination by coordinating cytoskeletal dynamics and scaffolding MAPK/ERK1/2 signaling, revealing a critical mechanism underlying age-related white matter degeneration.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of a preprint that has not been peer-reviewed. It is not medical advice. Do not make health decisions based on this content. Read full disclaimer
The brain is not just a collection of neurons firing signals; it is a vast network of wires wrapped in insulation. This insulation, called myelin, is a fatty sheath produced by specialized cells known as oligodendrocytes. Just as a frayed electrical wire causes a short circuit, damaged myelin disrupts communication in the nervous system, leading to the loss of vision, movement, and memory seen in conditions like multiple sclerosis and Alzheimer's disease. As we age, this protective coating naturally begins to wear down, and the brain's ability to repair itself often fails. The cells responsible for making new myelin, called oligodendrocyte precursor cells, are present in the aging brain, but they frequently get stuck before they can finish the job. They cannot transform into the mature cells needed to wrap around nerve fibers, leaving the brain vulnerable to degeneration. Understanding exactly why these repair cells stall is the key to unlocking treatments for age-related neurological decline.
Researchers at Dalian Medical University and other institutions have now identified a specific protein that acts as a critical switch for this repair process. They focused on a molecule called Sept7, which is found in the cells that build myelin. By studying mice and cells in the lab, the team discovered that Sept7 is essential for the physical changes a precursor cell must undergo to become a mature myelin-maker. Without enough Sept7, these cells cannot reshape themselves to wrap around nerve fibers, and the signals that tell them to grow simply do not work. The study reveals that Sept7 does two things at once: it organizes the cell's internal skeleton to allow for movement and shape-shifting, and it acts as a physical platform that helps a vital signaling pathway function correctly. When Sept7 is missing, both the structure and the signals break down, leaving the brain unable to repair its insulation.
To see how this protein behaves in a living system, the scientists first looked at the optic nerves of mice at different ages. They found that Sept7 is present in the cells that make myelin, and its levels rise as the brain matures and myelination peaks. However, when they removed Sept7 from adult mice, the myelin sheaths began to fall apart. The layers of insulation loosened, and the inner structures swelled, indicating that the protein is not just needed to build myelin but is also required to keep it intact over time. This suggested that a decline in Sept7 could be a major factor in why myelin deteriorates as we get older.
The team then tested whether Sept7 was necessary for the brain to repair itself after damage. They used two different methods to strip myelin from the optic nerves of mice: one involved a direct injection of a chemical to create a focal lesion, and the other involved feeding the mice a diet that causes widespread demyelination. In both cases, the researchers observed that Sept7 levels naturally dropped when the myelin was damaged and rose again as the repair process began. To confirm its role, they created mice where Sept7 was specifically removed from the precursor cells. When these mice suffered damage, they failed to recover their vision. Tests showed that their eyes could not process light signals properly, even though the nerve cells themselves were still alive. Under a microscope, the optic nerves of these mice showed very few new myelin sheaths, and the ones that did form were thin and disorganized. The precursor cells were there, but they had not grown into the mature cells needed to do the work.
Digging deeper into the cells themselves, the researchers found that the problem started with the cells' ability to change shape. In a healthy environment, precursor cells extend long, branching arms to wrap around nerve fibers. This process requires a dynamic internal skeleton made of protein filaments, specifically actin and microtubules. The scientists observed that when Sept7 was removed, the cells became round and stiff, unable to extend these necessary branches. They were stuck with short, stubby protrusions instead of the long, complex arms needed for myelination. The internal skeleton was disorganized; the actin filaments, which usually break down to allow the cell to move and expand, remained stuck in place. Similarly, the microtubules, which provide the structural tracks for transport within the cell, were clumped together in the wrong places. This disarray meant that mitochondria, the power plants of the cell, could not travel to the tips of the growing branches where they were needed for energy. Without the right shape and the energy to maintain it, the cells could not complete their transformation.
The study also uncovered a second, equally important role for Sept7. Beyond just holding the cell's structure together, Sept7 acts as a physical scaffold for a critical signaling pathway known as MAPK/ERK1/2. This pathway is like a communication line that tells the cell to grow and mature. The researchers found that Sept7 physically binds to the key proteins in this pathway, holding them in the right place so they can activate each other. When Sept7 was missing, this signaling line went silent. The proteins that should have been activated to tell the cell to differentiate remained inactive, and the genes required for making myelin were turned down. To prove that this physical connection was the key, the scientists created a version of Sept7 that could no longer bind to the signaling proteins. Even though the cell's skeleton was somewhat intact, the signaling failed, and the cells still could not mature. This confirmed that Sept7 is not just a structural glue but a vital organizer of the chemical messages that drive repair.
The findings suggest that the decline of Sept7 with age is a primary reason why the brain loses its ability to repair myelin. As the levels of this protein drop, the cells lose their ability to reshape themselves and their ability to receive the signals to grow. This dual failure leaves the brain's insulation vulnerable to the wear and tear of aging and disease. The research points to Sept7 as a potential target for future therapies. By finding ways to restore Sept7 levels or function, it might be possible to help the brain's repair cells overcome the barriers that currently stop them from fixing damaged myelin, offering a new hope for treating conditions where white matter damage is a central problem.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.